SBC Medical Group Holdings, a Tokyo-based company listed on NASDAQ, is at the forefront of transforming the healthcare industry by using AI-powered diagnostics and innovative service models to reduce administrative burdens for medical professionals. SBC manages 224 clinics in Japan and two internationally under the Shonen Beauty Clinic brand, offering services such as dermal fillers, laser hair removal, and cosmetic dental procedures. The company supports its franchisees with comprehensive operational assistance, allowing doctors to focus on patient care. As Japan's largest aesthetics medical group, SBC is expanding domestically and internationally, targeting growth in the U.S. and Southeast Asia. Japan's cosmetic surgery and medical aesthetics markets are projected to grow significantly by 2033. SBC's financial performance reflects its robust growth, with revenues rising and substantial cash reserves to support expansion. Following its public listing on NASDAQ via a SPAC merger, SBC presents a unique investment opportunity as it aims to scale its franchise model globally, benefiting healthcare professionals and shareholders.
Category
🗞
NewsTranscript
00:00Time is invaluable for healthcare professionals, yet many are burdened by administrative tasks.
00:08Innovations like AI-powered diagnostics and service organizations are helping medical
00:12professionals reclaim their focus on patient care.
00:16At the forefront of this trend is SBC Medical Group Holdings, NASDAQ, SBC, a Tokyo-based
00:23healthcare company pioneering a franchise model in the aesthetics industry.
00:27SBC leverages its expertise to manage 224 clinics in Japan and 2 internationally, operating
00:33under the Shonan Beauty Clinic brand.
00:36These clinics offer services like dermal fillers, laser hair removal, and cosmetic dental procedures.
00:43SBC supports franchisees with IT, marketing, payroll, clinic design, equipment procurement,
00:50and loyalty programs, streamlining operations so doctors can focus on patients.
00:55As Japan's largest aesthetic medical group, SBC continues to expand domestically while
01:00eyeing growth in the U.S. and Southeast Asia.
01:04Japan's cosmetic surgery market, valued at $19 billion in 2023, is projected to reach
01:11$41.6 billion by 2033, growing at a compound annual growth rate of 8.1%.
01:19Similarly, Japan's medical aesthetics market is expected to grow at a 13% compound annual
01:25growth rate, reaching $9 billion by 2033.
01:29SBC's fundamentals reflect its robust growth.
01:34In 2023, revenues rose 11% to $193 million, with EBITDA of $82 million.
01:42For Q1 2024, revenues surged 27.7% to $54.8 million, with net income of $18.7 million.
01:52The company holds $96 million in cash to support expansion efforts.
01:58Now publicly traded on NASDAQ following its SPAC merger, SBC offers investors a unique
02:03chance to participate in its early growth stages as it scales its franchise model globally.
02:09As a leader in Japan's thriving aesthetics market, SBC aims to replicate its success
02:14across new regions, creating value for healthcare professionals and shareholders alike.